Tennessee Oncology Physician Contributes to Landmark Longevity Research
Tennessee Oncology Physician Contributes to Landmark Longevity Research PR Newswire
Tennessee Oncology Physician Contributes to Landmark Longevity Research PR Newswire
Putting Patients at the Heart of Cancer Research – EORTC Oncodaily
FDA Approves Tukysa Combination as Maintenance for HER2-Positive Breast Cancer Cure Today
Вакцина от туберкулёза лечит рак мочевого пузыря: неожиданное применение, которое работает ИА Чеченинфо
“A Missed Mutation Can Mean a Missed Treatment”: Study Supports Two Approaches to ESR1 Testing Oncology News Central
Врачи бьют тревогу: В Латвии рак груди ежегодно выявляют более чем у тысячи женщин BB.LV
Врачи бьют тревогу: В Латвии рак груди ежегодно выявляют более чем у тысячи женщин BB.LV
Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer Business Wire
Скрытый резерв опухолевых клеток: как ошибка в системе регенерации привела к необратимому финалу Правда.Ру
A research team has developed an anticancer treatment platform that simultaneously targets cancer cells and the surrounding cells that support them while blocking communication between the two.
Exercise May Slow Biological Aging After Breast Cancer Cancer Nursing Today
Cedars-Sinai Cancer Advances Leadership Roles | Newswise Newswise
PharmaMar Joins OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition as Foundational Partner Oncodaily